Management reiterated confidence in long-term growth, citing nephrology's faster adoption and anticipated meaningful Q3 contribution. The company expects quarterly net cash flows to decrease for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback